On target: Genetically modified cells show promise in targeted immunotherapy for advanced blood cancers

E-ISSN： 1097-0142|120|7|929-930

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.7, 2014-04, pp. : 929-930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Genetically Modified T Cells for the Treatment of Malignant Disease

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 6, 2013-11 ,pp. : 388-402

Karger

Access to resources Recommend Favorite

Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy

MAGNETIC RESONANCE IN MEDICINE, Vol. 79, Iss. 2, 2018-02 ,pp. : 1010-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of renin: new evidence from cultured cells and genetically modified mice

By Bader Michael Ganten Detlev

Journal of Molecular Medicine, Vol. 78, Iss. 3, 2000-05 ,pp. : 130-139

Springer Publishing Company

Access to resources Recommend Favorite

Acid-sensitive nanoparticles filled with tumor-destroying drugs promise new method to target and kill ovarian cancer cells

Nanomedicine, Vol. 1, Iss. 3, 2006-10 ,pp. : 261-266

Future Medicine

Access to resources Recommend Favorite